Skip to Content

Tag: ResMed


Vendors

ResMed adds AirSense 11 to e-shop 

November 22, 2024Liz Beaulieu, Editor

SAN DIEGO – ResMed has added the AirSense 11 to its e-shop for cash purchase in a move that has upset providers who say they are still on allocation for this CPAP device.  When contacted by HME News, a company spokesperson confirmed that the AirSense 11 joined the AirSense 10 and AirMini, as well as numerous masks and accessories, on the company’s e-shop on Oct. 28.  “The expansion of our online shop reflects our broader commitment to developing a holistic channel...

AirSense 11, allocation, CPAP Device, e-shop, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed targets resupply, rePAP for growth

October 25, 2024Liz Beaulieu, Editor

SAN DIEGO – ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, performance and patient eligibility in real-time, available to all HME providers, not just those using Brightree.   The company reported a “really solid” 10% increase in sales for mask and accessories in the United States, Canada and Latin America for the first quarter of fiscal year 2025, on an “extraordinary comp” of 23% for...

CPAP, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed highlights ‘ongoing momentum’ 

October 25, 2024HME News Staff

SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025.  It reported net income of $311.4 million, a 42% increase.  Other results:  Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2%  Income from operations increased 34%; non-GAAP income from operations up 27%  Operating cash flow of $326 million  Diluted earnings per share of $2.11; non-GAAP diluted earnings per share...

Financial Results, ResMed


Read Full Articlered right arrow icon

News

In brief: Geriatric Medical buys DDP, ResMed talks strategy, NCPA launches new PBM ad 

October 2, 2024HME News Staff

WOBURN, Mass. – GMSS, the parent company of Geriatric Medical & Surgical Supply, has acquired DDP Medical Supply, significantly expanding its footprint and forming what it says is “the nation’s leading medical supply distribution networks focused on chronic, post-acute and home care providers.”  Both companies will maintain their unique brands and market-focused solutions, while benefiting from increased scale, enhanced distribution infrastructure and expanded service...

DDP Medical Supply, Geriatric Medical, National Community Pharmacists Association (NCPA), Pharmacy Benefit Managers (PBMs), ResMed


Read Full Articlered right arrow icon

Vendors

ResMed announces strategy, outlook 

October 1, 2024HME News Staff

SAN DIEGO – ResMed unveiled its 2030 strategy to drive growth, profitability and shareholder returns, including investing 7% in R&D, at an Investor Day in New York City.  The company also announced its five-year revenue and earnings growth outlook, reflecting its plans to accelerate product and technology innovation, operational excellence, commercial execution and financial strength.  “By building on our leadership in connected digital health, our 2030 Strategy will further...

CPAP Device, CPAP Mask, Outlook, ResMed, Strategy


Read Full Articlered right arrow icon

ResMed myAir

Also Noted

ResMed launches smartwatch app, health concierge, travel gear & fabric mask 

September 30, 2024HME News Staff

SAN DIEGO – ResMed has launched several patient-centric products designed to enhance their therapy for sleep apnea, including several new features for its myAir App. New features for myAir include smartwatch apps for Apple and Android, sleep staging from Apple Health and Health Connect, personalized coaching and holistic trending. “We know that digital wearables and other innovative technologies like AI can help consumers better understand their sleep habits and create a personalized...

Artificial Intelligence (AI), CPAP Mask, myAir, ResMed, smartwatch, travel gear


Read Full Articlered right arrow icon

News

In brief: Not guilty verdict, Tandem Diabetes recall, Healthcare Growth Group launch

August 23, 2024HME News Staff

SAN ANTONIO – Kuba Zarobkiewicz and Anthony Fermin, owners of DME companies, have been found not guilty of health care fraud, violations of the Anti-Kickback Statute and conspiracy charges by a federal jury.  Zarobkiewicz and Fermin ran brace businesses through multiple companies beginning in 2020 and then voluntarily shut them down in late 2021.  They began cooperating with a law enforcement investigation in September 2022 and then were charged in December 2022 in the Western District...

Healthcare Growth Group, Home Medical Equipment (HME), Medline, ResMed, Tandem Diabetes Care


Read Full Articlered right arrow icon

Also Noted

ResMed taps Billing Platform

August 22, 2024HME News Staff

DENVER – Billing Platform, an enterprise revenue lifecycle management platform, has announced that ResMed has selected its platform to automate its billing and subscription management, eliminating manual processes and reducing the risk of revenue leakage. ResMed is applying this digital health expertise more broadly through its SaaS business, offering comprehensive software platforms that support healthcare providers in settings outside of the hospital. "As our subscription offerings expand...

Billing Platform, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Also Noted

ResMed expands board of directors 

August 19, 2024HME News Staff

SAN DIEGO – ResMed has expanded the size of its board of directors to 11 and has elected Christopher DelOrefice to the board. DelOrefice, who currently serves as executive vice president and CFO of Becton, Dickinson and Company, was appointed during ResMed’s regularly scheduled board meeting on Aug. 15 and will stand for re-election with the rest of the company’s directors at its annual meeting on Nov. 21. “Chris has proven himself an experienced global leader in corporate...

Board of Directors, Christopher DelOrefice, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed: Demand is ‘incredibly strong’ 

August 1, 2024HME News Staff

SAN DIEGO – ResMed reported revenues of $1.2 billion for the fourth quarter of fiscal year 2024, a 9% increase year over year.  It reported a net income of $292.2 million vs. $229.7 million.  “Our fourth quarter and full-year fiscal year 2024 results demonstrate strong performance across all sectors of our business,” said Mick Farrell, chairman & CEO. “Ongoing patient and customer demand for our best-in-class products and software solutions is incredibly strong,...

Financial Results, ResMed


Read Full Articlered right arrow icon